Flowco valued at $2.55 bln as shares jump in strong NYSE debut-February 2024-www.financetom.com

Flowco valued at $2.55 bln as shares jump in strong NYSE debut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Flowco valued at $2.55 bln as shares jump in strong NYSE debut

Jan 16, 2025 10:28 AM

Jan 16 (Reuters) - Shares of Flowco Holdings ( FLOC )

opened nearly 21% above the initial public offering price in

their market debut on Thursday, giving the oilfield services

provider a market value of about $2.55 billion.

Previous page： BT Brands Shares Rise After Signing $3 Million-$5 Million All-Stock Merger Agreement With Aero Velocity Next page： Roblox Forms Partnership With IARC for Improved Age, Content Ratings

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BT Brands Shares Rise After Signing $3 Million-$5 Million All-Stock Merger Agreement With Aero Velocity

Sep 3, 2025

10:35 AM EDT, 09/03/2025 (MT Newswires) -- BT Brands ( BTBD ) shares were up 115% in recent trading on Wednesday after the restaurant operator and Aero Velocity, a drone technology company, announced an all-stock merger agreement. Under the terms of the deal, Aero Velocity stockholders will make an equity investment into the combined company in the range of $3...

Roblox Forms Partnership With IARC for Improved Age, Content Ratings

Sep 3, 2025

10:34 AM EDT, 09/03/2025 (MT Newswires) -- Roblox ( RBLX ) said Wednesday it formed a partnership with the International Age Rating Coalition or IARC to improve age and content ratings worldwide. The collaboration will replace Roblox's ( RBLX ) content maturity labels with region-specific ratings that reflect local cultural norms, helping families determine age-appropriate content, Roblox ( RBLX )...

Lantern Pharma Concludes Meeting With US FDA for Central Nervous System Cancers Study

Sep 3, 2025

10:34 AM EDT, 09/03/2025 (MT Newswires) -- Lantern Pharma ( LTRN ) said Wednesday that it concluded a meeting with the US Food and Drug Administration that provided guidance on a regulatory pathway for its planned pediatric study focused on central nervous system cancers, or CNS cancers, including atypical teratoid rhabdoid tumor. The oncology company said it received feedback on...

Hafnia to Acquire 14.45% of TORM Shares From Oaktree

Sep 3, 2025

10:36 AM EDT, 09/03/2025 (MT Newswires) -- Hafnia ( HAFN ) said Wednesday that the controlling shareholder of TORM ( TRMD ) has accepted its offer to acquire about 14.1 million class A shares in TORM ( TRMD ) at $22 per share for a total of around $311 million. The shares represent about 14.45% of TORM's ( TRMD )...